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Abstract 
	
This paper investigates how R&D investment intensity can infuse information asymmetry 
about the growth prospects and the idiosyncratic volatility of non-financial firms. Panel Data 
Method has been employed in order to regress idiosyncratic volatility on R&D investments. 
Using a sample of research-intensive FTSE-100 and S&P-100 firms having the highest market 
capitalization between 2008 and 2017, the study finds the evidence of a positive association in 
between R&D investment intensity and idiosyncratic component of total stock return volatility. 
The study provides the insight that R&D-led firms should leverage on their R&D related 
sensitive information to reduce the level of idiosyncratic volatility.     
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1.0	Introduction				
	
Total	stock	return	volatility	typically	determines	the	overall	financial	risk	of	a	firm.	This	
volatility	measure	can	be	classified	into	two	forms,	for	instance,	market-	related	risk	or	
systematic	risk,	and	firm-specific	risk	or	idiosyncratic	risk.	Campbell	et	al.	(2001)	show	
that	 firm	 specific	 idiosyncratic	 risk,	 i.e.	 the	 degree	 to	which	 firm	 specific	 returns	 are	
more	volatile	than	average	market	returns,	has	risen	since	the	1960s.	R&D	investments	
are	 pretty	 unique	 to	 the	 companies	 that	 execute	 the	 projects.	 As	 a	 result,	 R&D	 is	
accountable	 for	 generating	 asymmetry	 in	 information	 transmission	 about	 the	 firms’	
future	prospects	and	growth	potentials.	In	this	connection,	Aboody	and	Lev	(2000)	find	
the	evidence	that	 the	distinctiveness	of	R&D	investments	makes	 it	difficult	 for	general	
investors	 (the	 outsiders)	 to	 learn	 about	 the	 productivity	 and	 worth	 of	 a	 particular	
company’s	 R&D.	 This	may	 critically	 contribute	 to	 the	 information	 asymmetry	 for	 the	
R&D	 intensive	 firms	 relative	 to	 those	 having	 no	 R&D	 attempts.	 Accordingly,	 Gu	 and	
Wang	(2005)	provide	the	evidence	that	the	extent	of	informational	asymmetry	in	high-
tech	R&D	driven	companies	is	high	because	of	the	complication	and	technical	features	of	
innovation.			
			
A	 large	body	of	 literature	explores	the	riskiness	of	R&D	investments	and	document	that	
R&D	 intensive	 firms	 are	 riskier	 than	 those	 with	 no	 R&D	 intensity	 (Chan	 et	 al.	 2001;	
Kothari	et	al.	2002).	Goyal	and	Clara	(2003)	evaluate	the	similar	association	and	exhibit	
that	idiosyncratic	volatility	has	a	significant	impact	on	the	required	rate	of	return	on	the	
stock	 market.	 Furthermore,	 Xu	 (2006)	 examines	 how	 R&D	 strategies	 of	 US	 biotech	
companies	 influence	their	stock	price	volatility.	Taylor	(2008)	also	derives	 the	evidence	
that	 the	 presence	 of	 idiosyncratic	 volatility	 enhances	 the	 quality	 of	 market	 volatility	
predictions.	And,	Kearney	 and	Poti	 (2008)	 report	 the	 similar	 empirical	 results	 for	 the	
European	capital	markets.	The	finding	of	Mazzucato	and	Tancioni	(2008)	supports	the	
insight	that	the	more	the	R&D	intensity	a	firm	has,	the	greater	would	be	its	consequent	
idiosyncratic	risk.	Later	on,	Gharbi	et	al.	(2013)	examine	the	relationship	between	R&D	
investments	and	hi-tech	firms’	return	volatility	from	the	context	of	France	and	find	the	
evidence	 of	 a	 strong	 positive	 nexus	 between	 R&D	 investments	 intensity	 and	
idiosyncratic	risk.				
	
Up	until	now	most	of	the	earlier	studies	exclusively	concentrate	on	the	United	States.	This	
is	 because;	 the	 US	 firms	 constantly	 invest	 more	 in	 R&D	 activities	 than	 the	 European	
nations	 (Moncada	 et	 al.	 2010).	 Moreover,	 studies	 on	 European	 context	 hardly	 exist	
explicitly	 from	 the	 background	 of	 the	 United	 Kingdom.	 Hence,	 the	 present	 research	
proposes	R&D	 investment	as	a	 likely	determinant	of	 the	 idiosyncratic	volatility	 for	 the	
non-financial	 research-oriented	 UK	 firms	 under	 the	 FTSE-100	 Index	 and	 the	 non-
financial	research-led	US	firms	under	the	S&P-100	Index.						
	
R&D	 largely	 relies	 on	 size,	 gross	 profit	margin,	 and	 nature	 of	 business.	 Undoubtedly,	
R&D	expenditures	are	very	much	distinctive	to	a	particular	company.	The	more	the	R&D	
investments	 made	 by	 a	 company,	 the	 greater	 will	 be	 its	 variability	 in	 the	 business	
activities	 and	expected	 financial	 success.	Hence,	 it	 is	 anticipated	 that	R&D	 intensity	 is	
more	linked	to	the	idiosyncratic	part	of	total	volatility.	Therefore,	the	study	develops	the	
following	hypothesis:	
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Idiosyncratic	stock	volatility	is	positively	associated	with	the	R&D	investments.					
	
The	rest	of	the	paper	is	organized	as	follows:		
	
Chapter	 2	 focuses	 on	 the	 data	 and	methodology	 of	 the	 study.	 Chapter	 3	 provides	 the	
summary	measures	of	the	study,	i.e.	key	features	of	the	data	collected	from	both	the	UK	
and	the	USA	perspective.	Chapter	4	covers	the	analysis	and	discussion	of	the	empirical	
results.	 Finally,	 Chapter	 5	 presents	 the	 conclusion,	 implications	 of	 the	 study,	 and	 the	
scope	of	further	research.		
	
2.	Data	and	Methodology	
	
2.1	Details	of	the	variables				
	
Idiosyncratic	Volatility	(IDV)	
	
The	capital	markets	do	not	explain	 the	 idiosyncratic	volatility	or	 firm	specific	 risk.	So,	
Idiosyncratic	volatility	has	little	or	no	association	with	systematic	or	market	risk	factor.	
However,	 idiosyncratic	volatility	is	very	specific	to	a	firm.	For	instance,	 if	a	firm	has	to	
close	down	a	major	plant	because	of	a	natural	calamity,	its	share	price	may	be	affected	
whereas	the	rest	of	the	market	remains	unaffected.	Equivalently,	R&D	expenditures	are	
unique	to	a	firm.		
In	the	past,	researchers	employ	several	proxies	to	represent	idiosyncratic	volatility.	For	
instance,	Mazzucato	and	Tancioni	(2012)	consider	a	proxy	for	idiosyncratic	risk	which	
captures	 the	degree	 to	which	 firm-specific	 returns	 are	more	volatile	 than	 the	 average	
industry	returns:	the	log	ratio	between	the	standard	deviation	of	a	firm’s	return	and	the	
standard	deviation	of	the	average	industry	return.	However,	Gharbi	et	al.	(2013)	define	
idiosyncratic	volatility	as	 the	annualized	standard	deviation	of	weekly	errors	 from	the	
CAPM.	 Using	 the	 same	 formula	 in	 this	 study,	 idiosyncratic	 volatility	 has	 been	
characterized	by	 the	 annualized	 standard	deviation	 of	weekly	 errors	 from	 the	Capital	
Asset	Pricing	Model	(CAPM)	in	each	year.	Therefore,	natural	logarithm	of	idiosyncratic	
volatility	(IDV)	is	regarded	as	the	response	variable.	
							
R&D	Expenditures			
The	study	regards	R&D	as	the	ratio	of	R&D	expenses	to	sales.	Net	sales	or	revenue	has	
been	 treated	as	Sales.	Total	assets	 represent	 the	size	of	 the	 firm.	Natural	 logarithm	of	
total	 assets	 is	 utilized.	 This	 logarithmic	 transformation	 reduces	 both	 skewness	 and	
kurtosis	and	helps	obtain	the	end	results	fairly	closer	to	the	normal	distribution.	Table	
01	lists	the	definition	of	all	the	variables	along	with	abbreviations.	
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Name	of	the	variable	 Abbreviation	 																											Definition	
Idiosyncratic	Volatility	 IDV	 Annualized	 standard	 deviation	 of	 weekly	
errors	from	the	CAPM	Model	
R&D	Expenditures	 R&D		
(RnD	in	Stata)	
The	ratio	of	R&D	Expenditures	to	Sales	
Size	of	the	firm	 SIZE	 Natural	logarithm	of	Total	Assets	of	a	firm	
Leverage	 LEVERAGE	 The	ratio	of	Total	Debt	to	Total	Assets	
Table	01:	Definitions	of	variables	employed	in	this	study		
	
Besides,	 the	 study	 encompasses	 two	 control	 variables.	 Control	 variables,	 for	 example,	
size	and	leverage,	are	broadly	acknowledged	as	determinants	of	stock	return	volatility.	
Here,	Leverage	is	categorized	as	the	ratio	of	total	debt	to	total	assets	of	a	company.		In	
addition,	Size	is	generally	measured	as	the	total	assets	of	a	company.	The	logarithm	of	
total	 assets	 is	 taken	 as	 a	 control	 variable	 to	 derive	 the	 estimations.	 Two	 control	
variables	 included	 in	 this	 study	 are	meant	 to	 limit	 the	 bias	 of	 omitted	 variables	 and	
ensure	the	legitimacy	of	the	regression	model.				
	
2.2	Sample	
	
S&P-100	is	the	most	remarkable	stock	market	indicator	in	the	world	that	incorporates	
the	largest	100	US	firms	according	to	strong	company	fundamentals	and	highest	market	
capitalization.	The	S&P	100	 index	 is	a	subgroup	of	 the	broad	S&P	500	 index.	S&P	100	
accounts	 for	 about	 63%	 of	 the	 market	 capitalization	 of	 the	 S&P	 500	 index	 and	 also	
represents	almost	51%	of	the	entire	market	capitalization	of	the	US	equity	markets	as	of	
June	2017.	While	FTSE-100	is	by	far	the	most	widely	used	UK	capital	market	indicator.	
FTSE	100	occupies	around	81%	of	the	entire	market	capitalization	of	the	London	Stock	
Exchange	(LSE).	FTSE-100	firms	are	taken	into	account.		
	
Since,	 the	present	study	 is	based	on	both	the	UK	and	the	US	context,	 it	comprises	two	
independent	groups	of	sample	data	for	the	research.		
Table	02	shows	the	sample	summary	of	this	research:	
	
Table	02:	Overview	of	final	sample	of	the	study	
	
Datastream	5.0	version	has	been	accessed	to	accumulate	necessary	data	 for	 the	study.	
Altogether,	 five	 variables,	 regarding	 company	 performance	 indicators	 and	 business	
activities,	have	been	downloaded	from	Datastream.	Each	data	set	covers	information	of	
eligible	 sample	 firms	 for	 a	 period	 of	 10	 years	 between	 2008	 and	 2017.	 The	 study	
concentrates	 on	 a	 balanced	 panel	 that	 is	 labeled	 as	 strongly	 balanced	 by	 the	 data	
processing	software,	STATA.	Every	 single	 firm	underlying	 the	 study	has	 been	observed	
each	year.		
TARGET	
INDEX	
NUMBER	OF	TOTAL	
NON-FINANCIAL	
COMPANIES	
NUMBER	OF	
COMPANIES	WITH	R&D	
INTENSITY		
CROSS	
SECTIONS	OF	
SAMPLE	
TIME	SERIES	
OF	SAMPLE	
(YEARS)	
FTSE-100	 79	 43	 43	 10	
S&P-100	 84	 70	 70	 10	
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2.3	Model	Specification	
	
In	 order	 to	 choose	 the	 appropriate	model	 fit,	 pooled	OLS	 estimation,	 the	 fixed	 effects	
model,	and	the	random	effects	model	are	taken	into	account	in	this	study.	All	the	three	
models	are	demonstrated	below:	
	
i)	Pooled	Regression:		Pooled	OLS	applies	the	same	constant	α	for	all	the	sample	firms.	
The	model	can	be	signified	as:	
	Yit	=	α	+	β′Χit	+	εit																																																	(1)	
	
ii)	 The	 Fixed	 Effects	 Model:	 The	 fixed	 effects	 model	 permits	 the	 constant	 to	 vary	
between	 firms,	however,	 it	 is	 time	 invariant.	The	coefficients	 (αi)	make	 the	difference,	
which	indicate	unobservable	heterogeneity	or	individual	firm	specific	effects.	The	fixed	
effects	model	is	shown	below:		
																																																	Yit	=	αi		+	β′Χit	+	εit																																(2)	
	
iii)	Random	Effects	Model:	The	random	effects	model	entitles	the	constant	variable	as	a	
random	variable	that	can	be	shown	in	the	form	as	follows:				
αi	=	α	+	ui																																				(3)	
		
Overall,	this	model	can	be	written	as:		
																																																Yit		=	α	+	β′Χit	+	ui	+	εit																																							(4)	
	
To	 select	 the	 correct	 specification,	 the	 study	 conceives	 three	 tests.	 First,	 the	 F-test	
approves	 the	 significance	 of	 the	 fixed	 effects.	 Second,	 The	 Breusch	 and	 Pagan	 (1980)	
Lagrangian	 Multiplier	 test	 evaluates	 the	 relevance	 of	 the	 random	 effects.	 Third,	 the	
Hausman	 test	 (1978)	 distinguishes	 between	 the	 fixed	 effects	 model	 and	 the	 random	
effects	model.		
All	 the	 variables	 are	 winsorized	 at	 both	 upper	 and	 lower	 levels	 at	 1%	 of	 their	
distribution	in	a	manner	to	curb	the	impact	of	the	outliers	on	the	estimated	results.			
	
3.0:	Summary	Statistics	
	
Table	03	presents	 the	 summary	Statistics	 of	 the	UK	 firms	within	 the	FTSE-100	 Index.	
Firm	specific	or	idiosyncratic	volatility	measure	shows	an	average	of	44%.	Average	R&D	
investment	intensity	is	moderate	for	the	giant	firms.	UK	firms	allocate,	on	average,	2.5%	
of	their	sales	to	R&D	endeavor.	The	standard	deviation	of	R&D	is	4.70%.	
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Variable	 Observations	 Mean	 Standard	
Deviation	
Min	 Max	
R&D	 430	 2.524	 4.704	 0	 26.13	
TOTAL	ASSETS	
(Size)	
430	 15.88	 2.404	 1	 19.74	
DEBT	TO	ASSETS	
(Leverage)	
430	 26.884	 15.233	 0	 72.21	
IDIOSYNCRATIC	
VOLATILITY	
(IDV)	
430				 .4388		 .27423		 0	 1.746	
LN	(IDV)	 430	 -.90596	 0.53612	 2.09481	 0.55770	
Table	03:	Summary	statistics	of	the	UK	firms	under	the	FTSE-100		
	
Table	04,	similarly,	 lists	 the	summary	statistics	of	 the	research-driven	US	 firms	within	
the	 S&P-100	 Index.	 	 Here,	 idiosyncratic	 volatility	measure	 stands	 at	 39%	on	 average.	
The	 biggest	 US	 firms	 invest,	 on	 average,	 7%	 of	 their	 sales	 into	 R&D	 activity.		
Nonetheless,	the	standard	deviation	of	R&D	investment	intensity	is	little	over	8%.			
Table	04:	Summary	statistics	of	the	US	firms	under	the	S&P-100					
	
Skewness	and	Kurtosis	of	the	volatility	measures	are	as	follows:	
	
UK	context	 Skewness	 Kurtosis	 US	context	 Skewness	 Kurtosis	
IDV	 1.652157	 6.83381	 IDV	 1.255829	 5.959843	
LN	(IDV)	 0.292247	 2.570396	 LN	(IDV)	 0.240298	 2.778884	
Table	05:	Summary	details	of	idiosyncratic	volatility			
The	 volatility	 measure	 shows	 high	 magnitude	 of	 skewness	 and	 kurtosis.	 But	 log-
transformation	 lowers	 the	 level	 of	 skewness	 and	 kurtosis	 considerably.	 So,	 the	
distributions	of	the	log-transformed	variables	are	close	to	the	normal	distribution.			
	
	
	
	
	
	
Variable	 Observations	 Mean	 Standard	
Deviation	
Min	 Max	
R&D	 700	 6.823	 8.162	 0	 45.49	
TOTAL	ASSETS	
(Size)	
700	 17.311	 2.782	 1	 20.497	
DEBT	TO	ASSETS	
(Leverage)	
700	 25.509	 18.337	 0	 156.61	
IDIOSYNCRATIC	
VOLATILITY	(IDV)	
700	 .38988	 .22282	 0	 1.50987	
LN	(IDV)	 700	 -.96000	 .51270		 -2.21324		 .41202	
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4.0:	Empirical	Results		
Impact	of	R&D	on	the	idiosyncratic	volatility	(IDV)	
	
This	 study	 applies	 the	 following	 model	 to	 estimate	 the	 expected	 link	 between	 R&D	
investment	intensity	and	idiosyncratic	volatility:		
																													IDVit	=	β0	+	β1R&Dit	+	β2Leverageit	+	β3Sizeit	+	εit	
	
Independent	variables	 FTSE-100	(UK)	 							S&P-100	(US)	
R&D	 				0.0605**		
	(3.07)	
								0.0127***		
		(3.82)		
Leverage	 									0.00697***		
																						(3.77)	
							-0.00147*		
				(-2.10)	
Size	 					-0.0781**		
		(-2.64)	
									-0.0415***		
					(-3.42)	
Constant	 				1.365**		
		(3.01)	
									1.057***		
				(5.29)		
	 			N=430	 						N=700	
																	t	statistics	are	in	parentheses.	Asterisks	indicate	significance	level	
			*	p<0.05,		**	p<0.01,		***	p<0.001	
					Table	10:	Effects	of	R&D	on	idiosyncratic	volatility	
	
The	above	table	shows	the	regression	results	regarding	the	relationship	between	R&D	
investment	intensity	and	idiosyncratic	volatility.	At	first,	Breusch	and	Pagan	Lagrangian	
multiplier	test	has	been	performed.	Significant	p	value	of	Breusch	and	Pagan	Lagrangian	
multiplier	test	has	suggested	that	random	effects	model	is	more	fitting	than	the	pooled	
OLS	estimation	(Breusch	and	Pagan	LM	statistic:	140.87	with	a	P	value	of	0.0000).	Then,	
the	study	conducts	the	Hausman	test	to	pick	the	appropriate	specification	between	fixed	
effects	 and	 random	effects.	 Finally,	 significant	p	value	 corresponding	 to	Hausman	 test	
score	 recommends	 that	 fixed	 effects	 model	 is	 more	 suitable	 than	 the	 random	 effects	
model.		The	test	result	along	with	p	value	is	given	under:		
			
	Hausman	test													=							17.18					
																Prob	>	chi2																	=								0.0006					
	
Since	 the	 Hausman	 test	 statistic	 is	 significant	 at	 less	 than	 1%	 level,	 the	 fixed	 effects	
model	 specification	 has	 been	 chosen.	 In	 this	 model,	 idiosyncratic	 volatility	 has	 been	
regressed.	Here,	R&D	intensity	is	the	major	explanatory	variable	along	with	two	control	
variables.	Control	 variables	 are	Leverage	and	 firm	size.	The	estimated	 coefficients	 are	
0.0605	and	0.0127	for	the	UK	and	the	US	respectively.		The	coefficients	are	positive	and	
significant	at	the	1%	level	for	the	FTSE-100	and	0.1%	level	for	the	S&P-100.	In	fact,	R&D	
intensity	is	always	exclusive	to	a	firm.	A	firm	can	engage	in	more	R&D	activities	or	can	
do	 nothing	 at	 all.	 As	 a	 result,	 the	 impact	 of	 R&D	 investments	 on	 the	 idiosyncratic	
component	of	total	stock	return	volatility	is	substantial.	Thus,	this	finding	indicates	that	
the	idiosyncratic	volatility	is	positively	related	to	the	R&D	investments.		
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The	 Hausman	 test	 score	 for	 the	 S&P-100	 ensures	 that	 fixed	 effects	 model	 is	 more	
appropriate	 than	 the	 random	 effects	model	 since	 the	 p	 value	 is	 significant.	 	 The	 test	
result	together	with	the	p	value	is	given	under:		
				Hausman	test											=	12.42							
																		Prob	>	chi2															=	0.0061							
	
Likewise,	 the	 UK	 scenario,	 the	 influence	 of	 R&D	 investments	 on	 firm	 specific	 risk	 or	
idiosyncratic	 volatility	 is	 positive	 in	 the	 US	 context.	 This	 means	 the	 effect	 of	 R&D	
investments	 on	 the	 idiosyncratic	 component	 of	 total	 volatility	 is	 notable	 among	 the	
leading	US	firms.	Moreover,	firm	size	is	inversely	related	and	significant	at	less	than	1%	
level.	 	However,	 leverage	is	also	negatively	significant	at	the	5%	level	for	the	S&P-100.	
This	result	is	different	from	that	of	the	FTSE-100	case.	The	negative	impact	of	leverage	
in	the	US	context	infers	that	the	presence	of	debt	financing	produces	extensive	positive	
signaling	 effect	 for	 the	 large-cap	 firms	 to	 reduce	 the	 idiosyncratic	 volatility.	 Stata	
generated	regression	outputs	are	placed	in	the	Appendix.								
	
5.0:	Conclusion	
	
It	is	easy	to	understand	that	R&D	activities	and	required	investments	are	very	specific	to	
a	 firm	 that	 actually	 involves	 them.	 Thus,	 the	 study	 is	 based	 on	 the	 concept	 of	
idiosyncratic	 volatility	 to	 find	 the	 impact	 of	 firm-specific	 investment	 on	 firm-specific	
volatility.	 Based	 on	 the	 firms	 under	 the	 two	 indexes	 that	 invest	 in	 R&D,	 this	 study	
presents	the	evidence	that	idiosyncratic	volatility	is	positively	associated	with	the	R&D	
investment	 intensity.	 After	 controlling	 for	 leverage	 and	 firm	 size,	 the	 study	 regresses	
idiosyncratic	 volatility	 on	 R&D	 intensity.	 The	 finding	 of	 the	 study	 adds	 to	 the	 extant	
literature	by	offering	R&D	intensity	as	an	important	determinant	to	idiosyncratic	stock	
return	volatility.						
	
This	 research	 has	 broad	 implication	 for	 the	 finance	 managers	 who	 should	 work	 on	
maintaining	 effectual	 communication	 policy	 to	 decrease	 extreme	 informational	
asymmetry	 concerning	 R&D	 activities.	 The	 management	 of	 R&D	 specific	 information	
with	 caution	 is	 highly	 advised.	 The	 study	 also	 has	 influences	 on	 investors’	 risk	
calculation,	investment	analysis	and	portfolio	management	decisions	since	higher	level	
of	 idiosyncratic	 volatility	 is	 responsible	 for	 massive	 unpredictability	 of	 investment	
value.	Future	research	can	examine	the	nexus	between	R&D	intensity	and	the	valuation	
of	 derivative	 instruments.	 Also,	 the	 influence	 of	 several	 key	 firm	 characteristics	 on	
idiosyncratic	risk	can	be	appraised.		
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Appendix	
Effects	of	R&D	on	idiosyncratic	volatility		
	
UK:		
USA:	
	
	
F test that all u_i=0: F(69, 627) = 5.32                     Prob > F = 0.0000
                                                                              
         rho    .49500055   (fraction of variance due to u_i)
     sigma_e    .12265464
     sigma_u     .1214343
                                                                              
       _cons     1.056876   .1998772     5.29   0.000     .6643661    1.449386
        Size    -.0414618   .0121078    -3.42   0.001    -.0652386    -.017685
    Leverage    -.0014666   .0006994    -2.10   0.036    -.0028401   -.0000931
         RnD     .0126825   .0033218     3.82   0.000     .0061592    .0192057
                                                                              
         IDV        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = -0.6631                        Prob > F          =     0.0000
                                                F(3,627)          =      11.22
     overall = 0.0474                                         max =         10
     between = 0.0868                                         avg =       10.0
     within  = 0.0509                                         min =         10
R-sq:                                           Obs per group:
Group variable: companynum                      Number of groups  =         70
Fixed-effects (within) regression               Number of obs     =        700
. xtreg IDV RnD  Leverage Size , fe
F test that all u_i=0: F(42, 384) = 5.51                     Prob > F = 0.0000
                                                                              
         rho     .6764406   (fraction of variance due to u_i)
     sigma_e    .22815563
     sigma_u    .32988989
                                                                              
       _cons     1.365295   .4534373     3.01   0.003     .4737639    2.256825
        Size    -.0780841    .029552    -2.64   0.009     -.136188   -.0199801
    leverage     .0069687   .0018504     3.77   0.000     .0033305     .010607
         RnD     .0605133   .0197311     3.07   0.002     .0217188    .0993079
                                                                              
         IDV        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = -0.8554                        Prob > F          =     0.0002
                                                F(3,384)          =       6.73
     overall = 0.0004                                         max =         10
     between = 0.0083                                         avg =       10.0
     within  = 0.0499                                         min =         10
R-sq:                                           Obs per group:
Group variable: companynum                      Number of groups  =         43
Fixed-effects (within) regression               Number of obs     =        430
. xtreg IDV RnD leverage Size, fe
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UK	evidence	of	Idiosyncratic	Volatility:	Random	vs.	Fixed	Effects	
	
	
US	evidence	of	Idiosyncratic	Volatility:	Random	vs.	Fixed	Effects	
	
	
	
	
	
	
	
	
	
	
	
                Prob>chi2 =      0.0006
                          =       17.18
                  chi2(3) = (b-B)'[(V_b-V_B)^(-1)](b-B)
    Test:  Ho:  difference in coefficients not systematic
            B = inconsistent under Ha, efficient under Ho; obtained from xtreg
                           b = consistent under Ho and Ha; obtained from xtreg
                                                                              
        Size     -.0780841    -.0218032       -.0562809        .0256079
    Leverage      .0069687     .0023882        .0045805        .0012769
         RnD      .0605133     .0011274        .0593859        .0187048
                                                                              
                   fixed          .          Difference          S.E.
                    (b)          (B)            (b-B)     sqrt(diag(V_b-V_B))
                      Coefficients     
. hausman fixed 
                Prob>chi2 =      0.0061
                          =       12.42
                  chi2(3) = (b-B)'[(V_b-V_B)^(-1)](b-B)
    Test:  Ho:  difference in coefficients not systematic
            B = inconsistent under Ha, efficient under Ho; obtained from xtreg
                           b = consistent under Ho and Ha; obtained from xtreg
                                                                              
        Size     -.0414618    -.0296063       -.0118555        .0089616
    Leverage     -.0014666    -.0008348       -.0006318        .0004311
         RnD      .0126825     .0038524        .0088301          .00304
                                                                              
                   fixed        random       Difference          S.E.
                    (b)          (B)            (b-B)     sqrt(diag(V_b-V_B))
                      Coefficients     
. hausman fixed
